Relation of Changes in PEF and FEV 1 During Salbutamol‐Induced Bronchodilation After Methacholine Challenge Test
Pulmonary Medicine · 2025-01 · 2025 (1)
DOI: 10.1155/pm/7675935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pulmonary Medicine, online erschienen am 07.07.2025. Verfasst von Leon L Csonka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Albuterol, Methacholine Chloride, Asthma, Bronchial Provocation Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Väinö ja Laina Kiven Säätiö, Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö, Suomen Lääketieteen Säätiö.
Abstract (Originalsprache)
Asthma diagnosis can be confirmed by observing significant bronchodilator response (BDR) through peak expiratory flow (PEF) at home or forced expiratory volume in 1 s (FEV 1 ) via spirometry in a clinical setting. We aimed to use the administration of salbutamol after a methacholine challenge test as a model of bronchodilation to study how accurately the change in PEF predicts improvement in lung function, as defined by an increase in FEV 1 . We analyzed 869 adult patients who were administered salbutamol after a methacholine challenge. To compare relative changes in PEF and FEV 1 during bronchodilation, we used regression analysis and constructed a Bland and Altman plot. ROC analysis, sensitivity, specificity, positive and negative predictive values, and kappa coefficient assessed how precisely increases in PEF detected a 12% and 0.2‐L improvement in FEV 1 . The average relative increase in FEV 1 was significantly greater than that in PEF. The area under the curve in the ROC analysis was 0.844 for PEF change to detect a 12% and 0.2‐L increase in FEV 1 . The kappa values for changes in PEF and FEV 1 ranged from fair to moderate. BDR detected by the recommended 15% and 60 L/min cut‐off for PEF identified less than half of true positives, while a 10% cut‐off correctly identified close to 75% of them. PEF increase is not a reliable measure of BDR in comparison to FEV 1 increase, and a 10% improvement in PEF was the least inaccurate cut‐off. Substituting the PEF meter with a handheld spirometer should be further investigated for asthma home monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, Tampere, Finland.
- Allergy Centre, Tampere University Hospital, Tampere, Finland.
ORCID-Profile: Leon L Csonka
Förderung
- Väinö ja Laina Kiven Säätiö
- Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö
- Suomen Lääketieteen Säätiö
- Tays
- Hengityssairauksien Tutkimussäätiö
- Tampereen TuberkuloosisäätiÖ
Zitieren
APA
Csonka, L. L., Tikkakoski, A., Vuotari, L., Karjalainen, J., & Lehtimäki, L. (2025). Relation of Changes in PEF and FEV 1 During Salbutamol‐Induced Bronchodilation After Methacholine Challenge Test. Pulmonary Medicine, 2025(1). https://doi.org/10.1155/pm/7675935
Vancouver
Csonka LL, Tikkakoski A, Vuotari L, Karjalainen J, Lehtimäki L. Relation of Changes in PEF and FEV 1 During Salbutamol‐Induced Bronchodilation After Methacholine Challenge Test. Pulmonary Medicine. 2025;2025(1). doi:10.1155/pm/7675935
BibTeX
@article{Csonka2025,
author = {Csonka, Leon L and Tikkakoski, Antti and Vuotari, Liisa and Karjalainen, Jussi and Lehtimäki, Lauri},
title = {Relation of Changes in PEF and FEV 1 During Salbutamol‐Induced Bronchodilation After Methacholine Challenge Test},
journal = {Pulmonary Medicine},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/pm/7675935}
}
EUVIMED